腹部MRI特征与自身免疫性肝炎组织病理学严重程度及治疗应答的关联识别
回顾性纳入100例在肝活检3个月内行腹部增强MRI的自身免疫性肝炎患者,构建MRI及血清模型诊断严重组织病理学表现并预测治疗应答不足。MRI模型对严重汇管区炎症、融合性坏死、组织学活动度、肝硬化及应答不足的AUROC分别为0.765、0.796、0.748、0.833、0.796。结论认为MRI模型表现较好,联合血清模型可提升诊断与预后效能。
要点
- 腹水、网状纤维化及I段/全肝体积比用于诊断肝硬化,AUROC为0.833。
- 腹水、胆囊壁水肿及一过性肝灌注差异用于预测治疗应答不足,AUROC为0.796。
- V-VIII段/全肝体积比与网状纤维化参与严重汇管区炎症诊断,AUROC为0.765。
核心结论
- MRI模型在评估自身免疫性肝炎组织病理学严重程度和治疗应答方面表现出相对较好的效能。
- 联合MRI与血清模型可能提升诊断和预后效能。
研究设计与样本
- 回顾性纳入100例自身免疫性肝炎患者,中位年龄57.0岁,女性占79.0%。
- 纳入标准为肝活检3个月内行腹部增强MRI。
- 收集组织病理学严重程度、肝脏体积、MRI特征、实验室检查及治疗应答。
- 通过逐步单因素和多因素logistic回归构建MRI及血清模型。
关键影像表现/征象
- 严重汇管区炎症模型纳入网状纤维化和V-VIII段与全肝体积比。
- 严重融合性坏死模型纳入肝裂增宽、网状纤维化和I-III段与IV-VIII段体积比。
- 严重组织学活动度模型纳入腹水和V-VIII段与全肝体积比。
- 肝硬化模型纳入腹水、网状纤维化和I段与全肝体积比。
- 应答不足模型纳入腹水、胆囊壁水肿和一过性肝灌注差异。
诊断标准与关键数值
- 严重汇管区炎症诊断模型AUROC为0.765(95%CI 0.670-0.860)。
- 严重融合性坏死诊断模型AUROC为0.796(95%CI 0.708-0.885)。
- 严重组织学活动度诊断模型AUROC为0.748(95%CI 0.649-0.847)。
- 肝硬化诊断模型AUROC为0.833(95%CI 0.716-0.949)。
- 应答不足预测模型AUROC为0.796(95%CI 0.691-0.902);应答不足定义为免疫抑制治疗6个月后转氨酶和/或免疫球蛋白G仍未恢复正常。
临床应用与阅片要点
- 阅片时可关注腹水、网状纤维化、肝裂增宽、胆囊壁水肿及一过性肝灌注差异等征象。
- 可关注V-VIII段与全肝体积比、I-III段与IV-VIII段体积比、I段与全肝体积比等体积比值指标。
- 作者认为联合MRI与血清参数可为临床评估自身免疫性肝炎进展和治疗提供新的无创方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
UNLABELLED: To identify abdominal contrast magnetic resonance imaging (MRI) features associated with histopathological severity, and treatment response in autoimmune hepatitis (AIH).
PATIENTS AND METHODS: AIH patients who had abdominal contrast MRI within 3 months of liver biopsy were retrospectively enrolled. Histopathological severity, liver volume, MRI features, laboratory tests, and treatment response were collected. MRI and serum models were constructed through stepwise univariate and multivariate logistic regression for diagnosing severe histopathology and predicting insufficient response (IR).
RESULTS: One hundred AIH patients were included (median age: 57.0 years, 79.0% female). For diagnosing severe portal inflammation, reticular fibrosis and volume ratio of segment V-VIII to total liver (SV-SVIII/TLV) achieved an area under the receiver operating characteristic curve (AUROC) of 0.765 (95% CI 0.670-0.860). Severe confluent necrosis was modeled using hepatic fissure widening, reticular fibrosis, and volume ratio of segment I-III to segments IV-VIII, achieving an AUROC of 0.796 (95% CI 0.708-0.885). Severe histological activity was modeled using ascites, and SV-SVIII/TLV achieved an AUROC of 0.748 (95% CI 0.649-0.847). To diagnose cirrhosis, ascites, reticular fibrosis, and the volume ratio of segment I to the total liver were employed, yielding an AUROC of 0.833 (95% CI 0.716-0.949); IR (transaminases and/or immunoglobulin G remaining unnormal after 6 months of immunosuppressive treatment) was modeled using ascites, gallbladder wall edema, and transient hepatic attenuation difference, achieving an AUROC of 0.796 (95% CI 0.691-0.902).
CONCLUSION: The MRI models demonstrated relatively good performance in evaluating histopathological severity and treatment response. Combining MRI and serum models could enhance diagnostic and prognostic efficacy.
KEY POINTS: Question Abdominal contrast MRI may help clinicians better evaluate the histopathological severity and treatment response of autoimmune hepatitis (AIH), but there is currently limited research. Findings Models based on MRI features perform well in diagnosing severe portal inflammation, confluent necrosis, histological activity, and cirrhosis, as well as predicting insufficient response. Clinical relevance Abdominal contrast MRI, combined with serological parameters, provides a new and stronger noninvasive method for clinically assessing AIH progression and treatment.
引用
- Han X, Yang D, Su Y, et al. Identification of abdominal MRI features associated with histopathological severity and treatment response in autoimmune hepatitis. Eur Radiol. 2025. PMID: 40278875. doi:10.1007/s00330-025-11578-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。